ARA-290 supports cellular signaling modulation, mitochondrial energy production, gene expression regulation, and enzymatic activity, providing multifunctional capabilities for precise scientific studies
#ADA2026 #Obesity #Diabetes #GLP1 #DrugDevelopment #Pharma #Biotech To view or add a comment, sign in More Relevant Posts As the obesity drug development pipeline expands beyond injectable GLP-1s to include oral therapies and multi-mechanism compounds, pressure is mounting for researchers to predict efficacy, manage tolerability, and optimize to win in an increasingly competitive market
When you eat, nutrients in your gut stimulate these L-cells to release GLP-1
Pharmacology & Therapeutics
Because when you're eating less, your body doesn't just pull from fat stores, it can also break down lean muscle